Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Shaw

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Plos One|August 26, 2016
Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled TrialJ R Anderson, K Mortimer, L Pang, et al.
British Journal of Cancer|February 7, 2008
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)F Doñate, J C Juarez, M E Burnett, et al.
British Journal of Cancer|May 18, 2006
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumoursM E Cianfrocca, K A Kimmel, J Gallo, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.
Respiratory Medicine|April 10, 2019
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthmaK Tariq, J P R Schofield, B L Nicholas, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Plos One|August 26, 2016
Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled TrialJ R Anderson, K Mortimer, L Pang, et al.
British Journal of Cancer|February 7, 2008
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)F Doñate, J C Juarez, M E Burnett, et al.
British Journal of Cancer|May 18, 2006
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumoursM E Cianfrocca, K A Kimmel, J Gallo, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.
Respiratory Medicine|April 10, 2019
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthmaK Tariq, J P R Schofield, B L Nicholas, et al.
Pageof 5